Skip to main content

Table 1 Patient characteristics

From: Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway

Variable

Mean (± SD) or n (%)

Age at presentation (year)

66 (± 7.5)

PSA (ng/ml; n = 70)

8.1 (± 0.8)

Clinical T stage

T1c

42 (60%)

T2a

21 (30%)

T2b

5 (7%)

T2c

2 (3%)

PIRADS

 

4

38 (54%)

5

32 (46%)

SUV max (n = 70)

16.75 (21.72)

ISUP grade group (prostatectomy specimen)

No cancer

6 (8.5%)

1

17 (24.2%)

2

31 (44.3%)

3

10 (14.3%)

4

3 (4.3%)

5

3 (4.3%)

  1. ISUP = International Society of Urological Pathology; MRI = magnetic resonance imaging; PET = positron emission tomography; PIRADS = Prostate Imaging Reporting and Data System; PSA = prostate-specific antigen; SUVmax = maximum standardized uptake value